Literature DB >> 23731639

Psoriasis onset with tocilizumab.

Anne Grasland1, Emmanuel Mahé, Edouard Raynaud, Isabelle Mahé.   

Abstract

Entities:  

Keywords:  Psoriasis; Rheumatoid arthritis; Tocilizumab

Mesh：

Substances：

Year:  2013        PMID： 23731639     DOI： 10.1016/j.jbspin.2013.03.014

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  10 in total

1.  Is tocilizumab safe in Kaposi sarcoma? A complex association among rheumatoid arthritis, psoriasis, and Kaposi sarcoma.

Authors:  Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Clin Drug Investig       Date:  2014-06       Impact factor: 2.859

2.  Induction of Alternative Proinflammatory Cytokines Accounts for Sustained Psoriasiform Skin Inflammation in IL-17C+IL-6KO Mice.

Authors:  Yi Fritz; Philip A Klenotic; William R Swindell; Zhi Qiang Yin; Sarah G Groft; Li Zhang; Jaymie Baliwag; Maya I Camhi; Doina Diaconu; Andrew B Young; Alexander M Foster; Andrew Johnston; Johann E Gudjonsson; Thomas S McCormick; Nicole L Ward
Journal:  J Invest Dermatol       Date:  2016-10-27       Impact factor: 8.551

Review 3.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

4.  Association of Psoriasis with Autoimmune Disorders: Results of a Pilot Study.

Authors:  Sanket Vashist; Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan; Rajinder S Yadav; Satya Bhushan Sharma; Vikas Sharma; Anuj Sharma; Bhumika Chowdhary; Prabal Kumar
Journal:  Indian Dermatol Online J       Date:  2020-09-19

Review 5.  Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.

Authors:  Michitaro Hayakawa; Keisuke Izumi; Misako Higashida-Konishi; Mari Ushikubo; Masako Tsukamoto; Kumiko Akiya; Kazuhiro Araki; Hisaji Oshima
Journal:  Rheumatol Int       Date:  2018-10-24       Impact factor: 2.631

6.  Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.

Authors:  Yunmei Wang; Jackelyn B Golden; Yi Fritz; Xiufen Zhang; Doina Diaconu; Maya I Camhi; Huiyun Gao; Sean M Dawes; Xianying Xing; Santhi K Ganesh; Johann E Gudjonsson; Daniel I Simon; Thomas S McCormick; Nicole L Ward
Journal:  JCI Insight       Date:  2016-12-08

Review 7.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

8.  Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report.

Authors:  Xiao-Chuan Sun; Shuang Liu; Chen Li; Shuo Zhang; Mu Wang; Xiao-Hua Shi; Wei-Xin Hao; Wen Zhang
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

Review 9.  Current knowledge on psoriasis and autoimmune diseases.

Authors:  Nilmarie Ayala-Fontánez; David C Soler; Thomas S McCormick
Journal:  Psoriasis (Auckl)       Date:  2016-02-22

10.  Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis.

Authors:  Nan Ju; Munehisa Shimamura; Hiroki Hayashi; Yuka Ikeda; Shota Yoshida; Ayumi Nakamura; Ryuichi Morishita; Hiromi Rakugi; Hironori Nakagami
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.